Enhancing Identification of High-Risk cN0 Lung Adenocarcinoma Patients Using MRI-Based Radiomic Features
Cancer Research and Treatment · 2025
DOI: 10.4143/crt.2024.251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, 2025. Verfasst von Harim Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Magnetic Resonance Imaging. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Samsung Medical Center.
Abstract (Originalsprache)
Purpose
This study aimed to develop a magnetic resonance imaging (MRI)–based radiomics model to predict high-risk pathologic features for lung adenocarcinoma: micropapillary and solid pattern (MPsol), spread through air space, and poorly differentiated patterns.Materials and Methods As a prospective study, we screened clinical N0 lung cancer patients who were surgical candidates and had undergone both 18F-fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET/CT) and chest CT from August 2018 to January 2020. We recruited patients meeting our proposed imaging criteria indicating high-risk, that is, poorer prognosis of lung adenocarcinoma, using CT and FDG PET/CT. If possible, these patients underwent an MRI examination from which we extracted 77 radiomics features from T1-contrast-enhanced and T2-weighted images. Additionally, patient demographics, maximum standardized uptake value on FDG PET/CT, and the mean apparent diffusion coefficient value on diffusion-weighted image, were considered together to build prediction models for high-risk pathologic features.
Results
Among 616 patients, 72 patients met the imaging criteria for high-risk lung cancer and underwent lung MRI. The magnetic resonance (MR)–eligible group showed a higher prevalence of nodal upstaging (29.2% vs. 4.2%, p < 0.001), vascular invasion (6.5% vs. 2.1%, p=0.011), high-grade pathologic features (p < 0.001), worse 4-year disease-free survival (p < 0.001) compared with non-MR-eligible group. The prediction power for MR-based radiomics model predicting high-risk pathologic features was good, with mean area under the receiver operating curve (AUC) value measuring 0.751-0.886 in test sets. Adding clinical variables increased the predictive performance for MPsol and the poorly differentiated pattern using the 2021 grading system (AUC, 0.860 and 0.907, respectively).
Conclusion
Our imaging criteria can effectively screen high-risk lung cancer patients and predict high-risk pathologic features by our MR-based prediction model using radiomics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Electrical and Computer Engineering, Sungkyunkwan University, Suwon, Korea.
- Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea.
- Biomedical Statistics Center, Data Science Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Biomedical Statistics Center and Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Samsung Medical Center
- Institute of Information & communications Technology Planning & Evaluation
Zitieren
APA
Kim, H., Kim, J., Hwang, S., Oh, Y. J., Ahn, J. H., Kim, M. J., Hong, T. H., Park, S. G., Choi, J. Y., Kim, H. K., Kim, J., Shin, S., & Lee, H. Y. (2025). Enhancing Identification of High-Risk cN0 Lung Adenocarcinoma Patients Using MRI-Based Radiomic Features. Cancer Research and Treatment. https://doi.org/10.4143/crt.2024.251
Vancouver
Kim H, Kim J, Hwang S, Oh YJ, Ahn JH, Kim MJ, et al. Enhancing Identification of High-Risk cN0 Lung Adenocarcinoma Patients Using MRI-Based Radiomic Features. Cancer Research and Treatment. 2025. doi:10.4143/crt.2024.251
BibTeX
@article{Kim2025,
author = {Kim, Harim and Kim, Jonghoon and Hwang, Soohyun and Oh, You Jin and Ahn, Joong Hyun and Kim, Min-Ji and Hong, Tae Hee and Park, Sung Goo and Choi, Joon Young and Kim, Hong Kwan and Kim, Jhingook and Shin, Sumin and Lee, Ho Yun},
title = {Enhancing Identification of High-Risk cN0 Lung Adenocarcinoma Patients Using MRI-Based Radiomic Features},
journal = {Cancer Research and Treatment},
year = {2025},
doi = {10.4143/crt.2024.251}
}
EUVIMED